Signum Life Science

Just got home after an insightful three days in London at Reuters Events Pharma, Pharma Customer Engagement Europe 2024! Although I missed BIO-Europe, London really delivered invaluable insights, engaging discussions, and the chance to connect with so many brilliant people across the industry. From strategic dilemmas like “Do we want informed orchestrators or orchestrated executors?” to thought-provoking questions such as “How do we measure ROI?” and “Who truly owns the relationship—can organizations own it?”—the conversations were both challenging and inspiring. Of course, AI’s role was central, but so was the ongoing challenge with consent. Also need to highlight Richard Wrights talk - "Does Customer Experience really deliver business value?" And, as they say, when in Rome… I even got to experience some fantastic football London-style at Fulham Football Club with my colleague Allan Karne! ⚽️ Excited to bring these new perspectives and connections back to our work as we continue driving meaningful engagement in healthcare via our omnichannel tool—Kwarts by Signum Life Science. #PharmaEngagement #HealthcareInnovation #Omnichannel #CustomerExperience #Pharma #REcustomerEU24 #Signum

Hurra for en ny og ambitiøs life science-strategi 🙌 Regeringen har præsenteret en ny life science-strategi, som skal gøre Danmark til en global frontløber inden for sundhedsinnovation. Den har vi glædet os til længe - og med god grund. Det er nemlig spændende læsning. Strategien lægger op til store forbedringer inden for både forskning og udvikling og anvendelse af ny behandling i sundhedsvæsenet. Vi er især glade for ambitionerne om bedre deling af sundhedsdata, flere kliniske forsøg og støtte til avancerede terapier, som er vigtige skridt mod fremtidens sundhedsløsninger! “Strategien viser en klar forståelse af sektorens betydning for både sundhed og økonomi,” siger Ida Sofie Jensen. Læs mere her: https://lnkd.in/dRwkq4q9 Nu glæder vi os til, at strategiens mål bliver til virkelighed.

Presenting research is always insightful - but so is listening. 🏯 At the 16th Asian Conference on Pharmacoepidemiology, our ph.D. student Benedikte von Osmanski presented her scoping review on methods to assess drug effectiveness based on real-world data. But she left with even more than she brought: 👉 Fellow researchers shared their unique data access challenges - a reminder of the privileged position we hold in Denmark due to our high-quality nationwide health data. 👉A renowned researcher within causal inference shared insights on how RCTs and RWE address distinct research questions – and why both are essential to obtain the best clinical evidence. Bringing knowledge like this back home is essential. And we’re proud to have Benedikte’s work contribute to the foundation of evidence-based practice. Thank you, International Society for Pharmacoepidemiology, for hosting an inspiring event!

What we’re learning today can help patients tomorrow. That’s exactly why we attended the Danish Society for Pharmacoepidemiology's 30th Anniversary Meeting. Our Real-World Evidence team shared 3 research posters: 🔸Methods applied to assess real-world effectiveness of drugs: A scoping review by Benedikte von Osmanski 🔸Breast cancer incidence by subtypes - a Danish register-based study from 2012 to 2022 by Cathrine Tipsmark 🔸Private market uptake of varicella vaccination and related sociodemographic differences: A Danish nationwide observational study by Anne Cathrine Falch-Jørgensen Sharing knowledge from research is what moves healthcare forward, ensuring patients benefit from the newest, most effective treatments. Thank you for inviting us to be part of the event. 🙌

Last friday the Swedish Pharma Insights team gathered with Signum Life Science for an amazing kick-off with sailing at the Royal Danish Yachtklubb! ⛵️ Perfect conditions and experienced instructors made for a really nice experience (besides the blistered hands 👋) Thank you Signum Life Science 🙏🏻

Who wore it better: 1️⃣ or 2️⃣ ? I may not be as trendy as The Pink Panther (?) ...but I know a thing or two about 𝘵𝘳𝘦𝘯𝘥𝘴 and future opportunities for pharmaceutical companies in the Nordics. That's what I was invited to talk about at the Life Science Meetup this year (The occasion called for my best suit). Here are some points that stood out: 🔹Real-World Evidence is key for regulatory decisions 🔹Pharma-Public collaboration: challenging but rewarding 🔹The T-shaped professional is the most sought after If you missed the party, don't worry. You can learn more about the trends impacting Nordic pharma in our latest report, Forward Thinkers Review 2.0. The survey builds on data from 172 industry professionals, to which we added our extensive research and experience. Access it here: 👉 https://lnkd.in/dSBm6Vv7

Capturing the Life Science Meetup in drawings Yesterday, there were many good insights and discussions at the Life Science Meetup hosted by Lif - Lægemiddelindustriforeningen Signum Life Science etc. The Life Science House buzzed with collective energy as 350 people gathered to be inspired and shape the future of life science in Denmark. I was lucky enough to capture part of the discussions in sketches: 🚀 How can we boost Danish Life Science startups? There are many opportunities if we collaborate more across academia and industry and if we can change the culture. 🖥️ Denmark's new AI Supercomputer, a game-changer in the field of life science and innovation. 🌤️ A match made in heaven - Biotech & big pharma, There are many collaboration opportunities when we understand each others' needs. Which discussions would you have liked to hear?

Så er jeg lige kommer hjem efter en spændende dag fra årets Life Science Meetup hos Lif - Lægemiddelindustriforeningen sponsoret af DANISH BIO - DANSK BIOTEK Danish Life Science Cluster Signum Life Science Atrium Copenhagen Medicin.dk IT-Branchen Der var et væld af spændende indlæg fra både start-ups, det offentlige og de største virksomheder i branchen. Noget af det jeg bed mærke i, 1) fortsat manglende kommunikation og forståelse på tværs af sundhedssektoren 2) manglende adgang til sundhedsdata og langsomme regulative processer 3) og nærmest en åbenbaring for mig: et bedre sundhedsvæsen i fremtiden skal bruges mindre og læger skal lære at sige nej. Tak for inspirerende taler og samtaler til Ida Sofie Jensen Allan Karne Caroline Erup Widriksen Ebbe Steen Hansen Susie A. Ruff Søren-Ulrik Rolsted Fangholm Nicole Lønfeldt Kim Brixen Jonas Egebart Anette Lykke Petri Tore von Würden Diana Arsovic Anne Steinø

Jeg holder foredrag i dag i Life Science Huset om lægemiddelindustriens muligheder, udfordringer og must win battles over de næste 3 år. Der er nok at tage fat på. 👌🏻 Samtidigt lancerer vi Forward Thinkers Review 2024 hvor over 170 specialister fra industrien har givet deres bud på fremtiden for lægemiddelvirksomheder i Norden. Tag gerne kontakt til mig, hvis det er noget, du vil have mere indsigt i.